English
简体中文
Total: £ 56.28
Published Date: 2026-04-16 | Pages: 126 | Tables: 132 | Medical Care
The global Small Molecule Drug CDMO Services market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Small molecule drug CDMO services refer to outsourcing services for the development and production of small molecule drugs. CDMO (Contract Development and Manufacturing Organization) is a third-party organization that specializes in drug development and production. It provides customized services to pharmaceutical companies, covering the entire process from the drug development stage to the commercial production stage. CDMO services for small molecule drugs usually include drug development support, clinical trial support, production process optimization, commercial production, quality control and compliance support. By choosing CDMO services, pharmaceutical companies can focus on their core business and outsource drug R&D and production to professional organizations, thereby improving efficiency, reducing risks, and accelerating the launch of new drugs.
The North American market for Small Molecule Drug CDMO Services is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Small Molecule Drug CDMO Services is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Small Molecule Drug CDMO Services in Clinical Treatment is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Small Molecule Drug CDMO Services include Gliead, Boehringer Ingelheim, Vertex, Mirati Therapeutics, AMPAC, Pfizer, Polypeptide, Bachem, Merck, Asymchem, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Small Molecule Drug CDMO Services market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Small Molecule Drug CDMO Services. The Small Molecule Drug CDMO Services market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Small Molecule Drug CDMO Services market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Small Molecule Drug CDMO Services manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Gliead
Boehringer Ingelheim
Vertex
Mirati Therapeutics
AMPAC
Pfizer
Polypeptide
Bachem
Merck
Asymchem
Thermo Fisher Scientific
Zhejiang Jiuzhou Pharmaceutical
Porton Fine Chemicals
Lonza Group
JOINN Biologics
Zhejiang Langhua Pharmaceutical
Kingchem (Liaoning) Life Science
Segment by Type
Preparation
Chemical API
Segment by Application
Clinical Treatment
Medical Research
Commercial Production
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Small Molecule Drug CDMO Services companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Small Molecule Drug CDMO Services Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Preparation
1.2.3 Chemical API
1.3 Market by Application
1.3.1 Global Small Molecule Drug CDMO Services Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Clinical Treatment
1.3.3 Medical Research
1.3.4 Commercial Production
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Small Molecule Drug CDMO Services Market Perspective (2021–2032)
2.2 Global Small Molecule Drug CDMO Services Growth Trends by Region
2.2.1 Global Small Molecule Drug CDMO Services Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Small Molecule Drug CDMO Services Historic Market Size by Region (2021–2026)
2.2.3 Small Molecule Drug CDMO Services Forecasted Market Size by Region (2027–2032)
2.3 Small Molecule Drug CDMO Services Market Dynamics
2.3.1 Small Molecule Drug CDMO Services Industry Trends
2.3.2 Small Molecule Drug CDMO Services Market Drivers
2.3.3 Small Molecule Drug CDMO Services Market Challenges
2.3.4 Small Molecule Drug CDMO Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Small Molecule Drug CDMO Services Players by Revenue
3.1.1 Global Top Small Molecule Drug CDMO Services Players by Revenue (2021–2026)
3.1.2 Global Small Molecule Drug CDMO Services Revenue Market Share by Players (2021–2026)
3.2 Global Top Small Molecule Drug CDMO Services Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Small Molecule Drug CDMO Services Revenue
3.4 Global Small Molecule Drug CDMO Services Market Concentration Ratio
3.4.1 Global Small Molecule Drug CDMO Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Small Molecule Drug CDMO Services Revenue in 2025
3.5 Global Key Players of Small Molecule Drug CDMO Services Head Offices and Areas Served
3.6 Global Key Players of Small Molecule Drug CDMO Services, Products and Applications
3.7 Global Key Players of Small Molecule Drug CDMO Services, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Small Molecule Drug CDMO Services Breakdown Data by Type
4.1 Global Small Molecule Drug CDMO Services Historic Market Size by Type (2021–2026)
4.2 Global Small Molecule Drug CDMO Services Forecasted Market Size by Type (2027–2032)
5 Small Molecule Drug CDMO Services Breakdown Data by Application
5.1 Global Small Molecule Drug CDMO Services Historic Market Size by Application (2021–2026)
5.2 Global Small Molecule Drug CDMO Services Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Small Molecule Drug CDMO Services Market Size (2021–2032)
6.2 North America Small Molecule Drug CDMO Services Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Small Molecule Drug CDMO Services Market Size by Country (2021–2026)
6.4 North America Small Molecule Drug CDMO Services Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Small Molecule Drug CDMO Services Market Size (2021–2032)
7.2 Europe Small Molecule Drug CDMO Services Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Small Molecule Drug CDMO Services Market Size by Country (2021–2026)
7.4 Europe Small Molecule Drug CDMO Services Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Small Molecule Drug CDMO Services Market Size (2021–2032)
8.2 Asia-Pacific Small Molecule Drug CDMO Services Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Small Molecule Drug CDMO Services Market Size by Region (2021–2026)
8.4 Asia-Pacific Small Molecule Drug CDMO Services Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Small Molecule Drug CDMO Services Market Size (2021–2032)
9.2 Latin America Small Molecule Drug CDMO Services Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Small Molecule Drug CDMO Services Market Size by Country (2021–2026)
9.4 Latin America Small Molecule Drug CDMO Services Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Small Molecule Drug CDMO Services Market Size (2021–2032)
10.2 Middle East & Africa Small Molecule Drug CDMO Services Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Small Molecule Drug CDMO Services Market Size by Country (2021–2026)
10.4 Middle East & Africa Small Molecule Drug CDMO Services Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Gliead
11.1.1 Gliead Company Details
11.1.2 Gliead Business Overview
11.1.3 Gliead Small Molecule Drug CDMO Services Introduction
11.1.4 Gliead Revenue in Small Molecule Drug CDMO Services Business (2021–2026)
11.1.5 Gliead Recent Development
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Details
11.2.2 Boehringer Ingelheim Business Overview
11.2.3 Boehringer Ingelheim Small Molecule Drug CDMO Services Introduction
11.2.4 Boehringer Ingelheim Revenue in Small Molecule Drug CDMO Services Business (2021–2026)
11.2.5 Boehringer Ingelheim Recent Development
11.3 Vertex
11.3.1 Vertex Company Details
11.3.2 Vertex Business Overview
11.3.3 Vertex Small Molecule Drug CDMO Services Introduction
11.3.4 Vertex Revenue in Small Molecule Drug CDMO Services Business (2021–2026)
11.3.5 Vertex Recent Development
11.4 Mirati Therapeutics
11.4.1 Mirati Therapeutics Company Details
11.4.2 Mirati Therapeutics Business Overview
11.4.3 Mirati Therapeutics Small Molecule Drug CDMO Services Introduction
11.4.4 Mirati Therapeutics Revenue in Small Molecule Drug CDMO Services Business (2021–2026)
11.4.5 Mirati Therapeutics Recent Development
11.5 AMPAC
11.5.1 AMPAC Company Details
11.5.2 AMPAC Business Overview
11.5.3 AMPAC Small Molecule Drug CDMO Services Introduction
11.5.4 AMPAC Revenue in Small Molecule Drug CDMO Services Business (2021–2026)
11.5.5 AMPAC Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Small Molecule Drug CDMO Services Introduction
11.6.4 Pfizer Revenue in Small Molecule Drug CDMO Services Business (2021–2026)
11.6.5 Pfizer Recent Development
11.7 Polypeptide
11.7.1 Polypeptide Company Details
11.7.2 Polypeptide Business Overview
11.7.3 Polypeptide Small Molecule Drug CDMO Services Introduction
11.7.4 Polypeptide Revenue in Small Molecule Drug CDMO Services Business (2021–2026)
11.7.5 Polypeptide Recent Development
11.8 Bachem
11.8.1 Bachem Company Details
11.8.2 Bachem Business Overview
11.8.3 Bachem Small Molecule Drug CDMO Services Introduction
11.8.4 Bachem Revenue in Small Molecule Drug CDMO Services Business (2021–2026)
11.8.5 Bachem Recent Development
11.9 Merck
11.9.1 Merck Company Details
11.9.2 Merck Business Overview
11.9.3 Merck Small Molecule Drug CDMO Services Introduction
11.9.4 Merck Revenue in Small Molecule Drug CDMO Services Business (2021–2026)
11.9.5 Merck Recent Development
11.10 Asymchem
11.10.1 Asymchem Company Details
11.10.2 Asymchem Business Overview
11.10.3 Asymchem Small Molecule Drug CDMO Services Introduction
11.10.4 Asymchem Revenue in Small Molecule Drug CDMO Services Business (2021–2026)
11.10.5 Asymchem Recent Development
11.11 Thermo Fisher Scientific
11.11.1 Thermo Fisher Scientific Company Details
11.11.2 Thermo Fisher Scientific Business Overview
11.11.3 Thermo Fisher Scientific Small Molecule Drug CDMO Services Introduction
11.11.4 Thermo Fisher Scientific Revenue in Small Molecule Drug CDMO Services Business (2021–2026)
11.11.5 Thermo Fisher Scientific Recent Development
11.12 Zhejiang Jiuzhou Pharmaceutical
11.12.1 Zhejiang Jiuzhou Pharmaceutical Company Details
11.12.2 Zhejiang Jiuzhou Pharmaceutical Business Overview
11.12.3 Zhejiang Jiuzhou Pharmaceutical Small Molecule Drug CDMO Services Introduction
11.12.4 Zhejiang Jiuzhou Pharmaceutical Revenue in Small Molecule Drug CDMO Services Business (2021–2026)
11.12.5 Zhejiang Jiuzhou Pharmaceutical Recent Development
11.13 Porton Fine Chemicals
11.13.1 Porton Fine Chemicals Company Details
11.13.2 Porton Fine Chemicals Business Overview
11.13.3 Porton Fine Chemicals Small Molecule Drug CDMO Services Introduction
11.13.4 Porton Fine Chemicals Revenue in Small Molecule Drug CDMO Services Business (2021–2026)
11.13.5 Porton Fine Chemicals Recent Development
11.14 Lonza Group
11.14.1 Lonza Group Company Details
11.14.2 Lonza Group Business Overview
11.14.3 Lonza Group Small Molecule Drug CDMO Services Introduction
11.14.4 Lonza Group Revenue in Small Molecule Drug CDMO Services Business (2021–2026)
11.14.5 Lonza Group Recent Development
11.15 JOINN Biologics
11.15.1 JOINN Biologics Company Details
11.15.2 JOINN Biologics Business Overview
11.15.3 JOINN Biologics Small Molecule Drug CDMO Services Introduction
11.15.4 JOINN Biologics Revenue in Small Molecule Drug CDMO Services Business (2021–2026)
11.15.5 JOINN Biologics Recent Development
11.16 Zhejiang Langhua Pharmaceutical
11.16.1 Zhejiang Langhua Pharmaceutical Company Details
11.16.2 Zhejiang Langhua Pharmaceutical Business Overview
11.16.3 Zhejiang Langhua Pharmaceutical Small Molecule Drug CDMO Services Introduction
11.16.4 Zhejiang Langhua Pharmaceutical Revenue in Small Molecule Drug CDMO Services Business (2021–2026)
11.16.5 Zhejiang Langhua Pharmaceutical Recent Development
11.17 Kingchem (Liaoning) Life Science
11.17.1 Kingchem (Liaoning) Life Science Company Details
11.17.2 Kingchem (Liaoning) Life Science Business Overview
11.17.3 Kingchem (Liaoning) Life Science Small Molecule Drug CDMO Services Introduction
11.17.4 Kingchem (Liaoning) Life Science Revenue in Small Molecule Drug CDMO Services Business (2021–2026)
11.17.5 Kingchem (Liaoning) Life Science Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Small Molecule Drug CDMO Services Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Preparation
Table 3. Key Players of Chemical API
Table 4. Global Small Molecule Drug CDMO Services Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 5. Global Small Molecule Drug CDMO Services Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Small Molecule Drug CDMO Services Market Size by Region (US$ Million), 2021–2026
Table 7. Global Small Molecule Drug CDMO Services Market Share by Region (2021–2026)
Table 8. Global Small Molecule Drug CDMO Services Forecasted Market Size by Region (US$ Million), 2027–2032
Table 9. Global Small Molecule Drug CDMO Services Market Share by Region (2027–2032)
Table 10. Small Molecule Drug CDMO Services Market Trends
Table 11. Small Molecule Drug CDMO Services Market Drivers
Table 12. Small Molecule Drug CDMO Services Market Challenges
Table 13. Small Molecule Drug CDMO Services Market Restraints
Table 14. Global Small Molecule Drug CDMO Services Revenue by Players (US$ Million), 2021–2026
Table 15. Global Small Molecule Drug CDMO Services Market Share by Players (2021–2026)
Table 16. Global Top Small Molecule Drug CDMO Services Players by Tier (Tier 1, Tier 2, and Tier 3), based on Small Molecule Drug CDMO Services Revenue, 2025
Table 17. Ranking of Global Top Small Molecule Drug CDMO Services Companies by Revenue (US$ Million) in 2025
Table 18. Global 5 Largest Players Market Share by Small Molecule Drug CDMO Services Revenue (CR5 and HHI), 2021–2026
Table 19. Global Key Players of Small Molecule Drug CDMO Services, Headquarters and Area Served
Table 20. Global Key Players of Small Molecule Drug CDMO Services, Products and Applications
Table 21. Global Key Players of Small Molecule Drug CDMO Services, Date of General Availability (GA)
Table 22. Mergers and Acquisitions, Expansion Plans
Table 23. Global Small Molecule Drug CDMO Services Market Size by Type (US$ Million), 2021–2026
Table 24. Global Small Molecule Drug CDMO Services Revenue Market Share by Type (2021–2026)
Table 25. Global Small Molecule Drug CDMO Services Forecasted Market Size by Type (US$ Million), 2027–2032
Table 26. Global Small Molecule Drug CDMO Services Revenue Market Share by Type (2027–2032)
Table 27. Global Small Molecule Drug CDMO Services Market Size by Application (US$ Million), 2021–2026
Table 28. Global Small Molecule Drug CDMO Services Revenue Market Share by Application (2021–2026)
Table 29. Global Small Molecule Drug CDMO Services Forecasted Market Size by Application (US$ Million), 2027–2032
Table 30. Global Small Molecule Drug CDMO Services Revenue Market Share by Application (2027–2032)
Table 31. North America Small Molecule Drug CDMO Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 32. North America Small Molecule Drug CDMO Services Market Size by Country (US$ Million), 2021–2026
Table 33. North America Small Molecule Drug CDMO Services Market Size by Country (US$ Million), 2027–2032
Table 34. Europe Small Molecule Drug CDMO Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. Europe Small Molecule Drug CDMO Services Market Size by Country (US$ Million), 2021–2026
Table 36. Europe Small Molecule Drug CDMO Services Market Size by Country (US$ Million), 2027–2032
Table 37. Asia-Pacific Small Molecule Drug CDMO Services Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 38. Asia-Pacific Small Molecule Drug CDMO Services Market Size by Region (US$ Million), 2021–2026
Table 39. Asia-Pacific Small Molecule Drug CDMO Services Market Size by Region (US$ Million), 2027–2032
Table 40. Latin America Small Molecule Drug CDMO Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 41. Latin America Small Molecule Drug CDMO Services Market Size by Country (US$ Million), 2021–2026
Table 42. Latin America Small Molecule Drug CDMO Services Market Size by Country (US$ Million), 2027–2032
Table 43. Middle East & Africa Small Molecule Drug CDMO Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Middle East & Africa Small Molecule Drug CDMO Services Market Size by Country (US$ Million), 2021–2026
Table 45. Middle East & Africa Small Molecule Drug CDMO Services Market Size by Country (US$ Million), 2027–2032
Table 46. Gliead Company Details
Table 47. Gliead Business Overview
Table 48. Gliead Small Molecule Drug CDMO Services Product
Table 49. Gliead Revenue in Small Molecule Drug CDMO Services Business (US$ Million), 2021–2026
Table 50. Gliead Recent Development
Table 51. Boehringer Ingelheim Company Details
Table 52. Boehringer Ingelheim Business Overview
Table 53. Boehringer Ingelheim Small Molecule Drug CDMO Services Product
Table 54. Boehringer Ingelheim Revenue in Small Molecule Drug CDMO Services Business (US$ Million), 2021–2026
Table 55. Boehringer Ingelheim Recent Development
Table 56. Vertex Company Details
Table 57. Vertex Business Overview
Table 58. Vertex Small Molecule Drug CDMO Services Product
Table 59. Vertex Revenue in Small Molecule Drug CDMO Services Business (US$ Million), 2021–2026
Table 60. Vertex Recent Development
Table 61. Mirati Therapeutics Company Details
Table 62. Mirati Therapeutics Business Overview
Table 63. Mirati Therapeutics Small Molecule Drug CDMO Services Product
Table 64. Mirati Therapeutics Revenue in Small Molecule Drug CDMO Services Business (US$ Million), 2021–2026
Table 65. Mirati Therapeutics Recent Development
Table 66. AMPAC Company Details
Table 67. AMPAC Business Overview
Table 68. AMPAC Small Molecule Drug CDMO Services Product
Table 69. AMPAC Revenue in Small Molecule Drug CDMO Services Business (US$ Million), 2021–2026
Table 70. AMPAC Recent Development
Table 71. Pfizer Company Details
Table 72. Pfizer Business Overview
Table 73. Pfizer Small Molecule Drug CDMO Services Product
Table 74. Pfizer Revenue in Small Molecule Drug CDMO Services Business (US$ Million), 2021–2026
Table 75. Pfizer Recent Development
Table 76. Polypeptide Company Details
Table 77. Polypeptide Business Overview
Table 78. Polypeptide Small Molecule Drug CDMO Services Product
Table 79. Polypeptide Revenue in Small Molecule Drug CDMO Services Business (US$ Million), 2021–2026
Table 80. Polypeptide Recent Development
Table 81. Bachem Company Details
Table 82. Bachem Business Overview
Table 83. Bachem Small Molecule Drug CDMO Services Product
Table 84. Bachem Revenue in Small Molecule Drug CDMO Services Business (US$ Million), 2021–2026
Table 85. Bachem Recent Development
Table 86. Merck Company Details
Table 87. Merck Business Overview
Table 88. Merck Small Molecule Drug CDMO Services Product
Table 89. Merck Revenue in Small Molecule Drug CDMO Services Business (US$ Million), 2021–2026
Table 90. Merck Recent Development
Table 91. Asymchem Company Details
Table 92. Asymchem Business Overview
Table 93. Asymchem Small Molecule Drug CDMO Services Product
Table 94. Asymchem Revenue in Small Molecule Drug CDMO Services Business (US$ Million), 2021–2026
Table 95. Asymchem Recent Development
Table 96. Thermo Fisher Scientific Company Details
Table 97. Thermo Fisher Scientific Business Overview
Table 98. Thermo Fisher Scientific Small Molecule Drug CDMO Services Product
Table 99. Thermo Fisher Scientific Revenue in Small Molecule Drug CDMO Services Business (US$ Million), 2021–2026
Table 100. Thermo Fisher Scientific Recent Development
Table 101. Zhejiang Jiuzhou Pharmaceutical Company Details
Table 102. Zhejiang Jiuzhou Pharmaceutical Business Overview
Table 103. Zhejiang Jiuzhou Pharmaceutical Small Molecule Drug CDMO Services Product
Table 104. Zhejiang Jiuzhou Pharmaceutical Revenue in Small Molecule Drug CDMO Services Business (US$ Million), 2021–2026
Table 105. Zhejiang Jiuzhou Pharmaceutical Recent Development
Table 106. Porton Fine Chemicals Company Details
Table 107. Porton Fine Chemicals Business Overview
Table 108. Porton Fine Chemicals Small Molecule Drug CDMO Services Product
Table 109. Porton Fine Chemicals Revenue in Small Molecule Drug CDMO Services Business (US$ Million), 2021–2026
Table 110. Porton Fine Chemicals Recent Development
Table 111. Lonza Group Company Details
Table 112. Lonza Group Business Overview
Table 113. Lonza Group Small Molecule Drug CDMO Services Product
Table 114. Lonza Group Revenue in Small Molecule Drug CDMO Services Business (US$ Million), 2021–2026
Table 115. Lonza Group Recent Development
Table 116. JOINN Biologics Company Details
Table 117. JOINN Biologics Business Overview
Table 118. JOINN Biologics Small Molecule Drug CDMO Services Product
Table 119. JOINN Biologics Revenue in Small Molecule Drug CDMO Services Business (US$ Million), 2021–2026
Table 120. JOINN Biologics Recent Development
Table 121. Zhejiang Langhua Pharmaceutical Company Details
Table 122. Zhejiang Langhua Pharmaceutical Business Overview
Table 123. Zhejiang Langhua Pharmaceutical Small Molecule Drug CDMO Services Product
Table 124. Zhejiang Langhua Pharmaceutical Revenue in Small Molecule Drug CDMO Services Business (US$ Million), 2021–2026
Table 125. Zhejiang Langhua Pharmaceutical Recent Development
Table 126. Kingchem (Liaoning) Life Science Company Details
Table 127. Kingchem (Liaoning) Life Science Business Overview
Table 128. Kingchem (Liaoning) Life Science Small Molecule Drug CDMO Services Product
Table 129. Kingchem (Liaoning) Life Science Revenue in Small Molecule Drug CDMO Services Business (US$ Million), 2021–2026
Table 130. Kingchem (Liaoning) Life Science Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
Table 134. Authors List of This Report
List of Figures
Figure 1. Small Molecule Drug CDMO Services Picture
Figure 2. Global Small Molecule Drug CDMO Services Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Small Molecule Drug CDMO Services Market Share by Type: 2025 vs 2032
Figure 4. Preparation Features
Figure 5. Chemical API Features
Figure 6. Global Small Molecule Drug CDMO Services Market Size by Application (US$ Million), 2021–2032
Figure 7. Global Small Molecule Drug CDMO Services Market Share by Application: 2025 vs 2032
Figure 8. Clinical Treatment Case Studies
Figure 9. Medical Research Case Studies
Figure 10. Commercial Production Case Studies
Figure 11. Small Molecule Drug CDMO Services Report Years Considered
Figure 12. Global Small Molecule Drug CDMO Services Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 13. Global Small Molecule Drug CDMO Services Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Small Molecule Drug CDMO Services Market Share by Region: 2025 vs 2032
Figure 15. Global Small Molecule Drug CDMO Services Market Share by Players in 2025
Figure 16. Global Small Molecule Drug CDMO Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 17. The Top 10 and 5 Players Market Share by Small Molecule Drug CDMO Services Revenue in 2025
Figure 18. North America Small Molecule Drug CDMO Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 19. North America Small Molecule Drug CDMO Services Market Share by Country (2021–2032)
Figure 20. United States Small Molecule Drug CDMO Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. Canada Small Molecule Drug CDMO Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Europe Small Molecule Drug CDMO Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe Small Molecule Drug CDMO Services Market Share by Country (2021–2032)
Figure 24. Germany Small Molecule Drug CDMO Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. France Small Molecule Drug CDMO Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. U.K. Small Molecule Drug CDMO Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Italy Small Molecule Drug CDMO Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Russia Small Molecule Drug CDMO Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Ireland Small Molecule Drug CDMO Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Asia-Pacific Small Molecule Drug CDMO Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific Small Molecule Drug CDMO Services Market Share by Region (2021–2032)
Figure 32. China Small Molecule Drug CDMO Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Japan Small Molecule Drug CDMO Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. South Korea Small Molecule Drug CDMO Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Southeast Asia Small Molecule Drug CDMO Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. India Small Molecule Drug CDMO Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Australia & New Zealand Small Molecule Drug CDMO Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Latin America Small Molecule Drug CDMO Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America Small Molecule Drug CDMO Services Market Share by Country (2021–2032)
Figure 40. Mexico Small Molecule Drug CDMO Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Brazil Small Molecule Drug CDMO Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Middle East & Africa Small Molecule Drug CDMO Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa Small Molecule Drug CDMO Services Market Share by Country (2021–2032)
Figure 44. Israel Small Molecule Drug CDMO Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Saudi Arabia Small Molecule Drug CDMO Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. UAE Small Molecule Drug CDMO Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Gliead Revenue Growth Rate in Small Molecule Drug CDMO Services Business (2021–2026)
Figure 48. Boehringer Ingelheim Revenue Growth Rate in Small Molecule Drug CDMO Services Business (2021–2026)
Figure 49. Vertex Revenue Growth Rate in Small Molecule Drug CDMO Services Business (2021–2026)
Figure 50. Mirati Therapeutics Revenue Growth Rate in Small Molecule Drug CDMO Services Business (2021–2026)
Figure 51. AMPAC Revenue Growth Rate in Small Molecule Drug CDMO Services Business (2021–2026)
Figure 52. Pfizer Revenue Growth Rate in Small Molecule Drug CDMO Services Business (2021–2026)
Figure 53. Polypeptide Revenue Growth Rate in Small Molecule Drug CDMO Services Business (2021–2026)
Figure 54. Bachem Revenue Growth Rate in Small Molecule Drug CDMO Services Business (2021–2026)
Figure 55. Merck Revenue Growth Rate in Small Molecule Drug CDMO Services Business (2021–2026)
Figure 56. Asymchem Revenue Growth Rate in Small Molecule Drug CDMO Services Business (2021–2026)
Figure 57. Thermo Fisher Scientific Revenue Growth Rate in Small Molecule Drug CDMO Services Business (2021–2026)
Figure 58. Zhejiang Jiuzhou Pharmaceutical Revenue Growth Rate in Small Molecule Drug CDMO Services Business (2021–2026)
Figure 59. Porton Fine Chemicals Revenue Growth Rate in Small Molecule Drug CDMO Services Business (2021–2026)
Figure 60. Lonza Group Revenue Growth Rate in Small Molecule Drug CDMO Services Business (2021–2026)
Figure 61. JOINN Biologics Revenue Growth Rate in Small Molecule Drug CDMO Services Business (2021–2026)
Figure 62. Zhejiang Langhua Pharmaceutical Revenue Growth Rate in Small Molecule Drug CDMO Services Business (2021–2026)
Figure 63. Kingchem (Liaoning) Life Science Revenue Growth Rate in Small Molecule Drug CDMO Services Business (2021–2026)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
